Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Aquestive Therapeutics Enters License Agreement with Eton Pharmaceuticals for LIBERVANT®
Contract Type
licensing
Description
On October 13, 2026, Aquestive Therapeutics, Inc. entered into a license agreement granting Eton Pharmaceuticals exclusive U.S. rights to commercialize LIBERVANT® buccal film for seizure clusters in epilepsy patients. The deal includes an upfront fee of $10.0 million and further milestone payments totaling up to $47.5 million
Related People
Aquestive Therapeutics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.